Arkolith/Insider Trading/AZYO/Form 4

Ferguson Matthew

CHIEF FINANCIAL OFFICERAZIYO BIOLOGICS, INC. (AZYO) · full profile →Form 4 · filed Mar 10, 2022
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
5
1 non-derivative · 4 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 8, 2022Option exercise(M)1K—$08K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Mar 8, 2022Grant(A)31K—$031K
Mar 8, 2022Grant(A)14K—$014K
Mar 8, 2022Option exercise(M)1K—$04K
Mar 8, 2022Grant(A)9K—$09K

Transaction Codes

M
Option exercise / conversion
A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001415889-22-002860) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML